Tomczak, Piotr. “Cabozantinib in Monotherapy and Combination Therapy for First-Line Renal Cell Carcinoma: Patient Profiles”. OncoReview 15, no. 1(57) (June 30, 2025): 12-17. Accessed January 14, 2026. https://www.journalsmededu.pl/index.php/OncoReview/article/view/3361.